NASDAQ: MESO
Mesoblast Ltd Stock Ownership - Who owns Mesoblast?

Insider buying vs selling

Have Mesoblast Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when MESO insiders and whales buy or sell their stock.

MESO Shareholders

What type of owners hold Mesoblast Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc0.06%714,928$8.42MInstitution
Morgan Stanley0.05%544,557$6.41MInstitution
Citadel Advisors LLC0.04%486,793$5.73MInstitution
Susquehanna International Group LLP0.02%260,941$3.07MInstitution
Goldman Sachs Group Inc0.02%257,143$3.03MInstitution
Summit X LLC0.02%198,163$2.33MInstitution
Group One Trading LLC0.01%151,231$1.78MInstitution
Toronto Dominion Bank0.01%150,000$1.77MInstitution
Ubs Group Ag0.01%140,495$1.66MInstitution
Penbrook Management LLC0.01%87,675$1.03MInstitution

1 of 3

MESO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MESO0.33%0.00%
INVA57.75%42.25%Net SellingNet Selling
OCUL79.09%20.91%Net SellingNet Selling
CLDX85.27%14.73%Net Buying
VRDN74.88%25.12%Net BuyingNet Buying

Mesoblast Stock Ownership FAQ

Who owns Mesoblast?

Mesoblast (NASDAQ: MESO) is owned by 0.33% institutional shareholders, 0.00% Mesoblast insiders, and 99.67% retail investors. Blackrock Inc is the largest individual Mesoblast shareholder, owning 714,928.00 shares representing 0.06% of the company. Blackrock Inc's Mesoblast shares are currently valued at $8.42M.

If you're new to stock investing, here's how to buy Mesoblast stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.